Structural Heart Program: Definition, Uses, and Clinical Overview

Posted on February 27, 2026 | by drspine

Structural Heart Program Introduction (What it is)

A Structural Heart Program is a coordinated hospital or health-system service focused on diseases of the heart’s “structures,” especially the valves and internal walls of the heart.
It brings together multiple specialists to evaluate symptoms, confirm diagnoses, and plan procedures when needed.
It is commonly used in cardiology centers that offer advanced imaging and catheter-based (minimally invasive) heart interventions.
It may also support surgical care when an open operation is the better fit for a specific condition.

Why Structural Heart Program used (Purpose / benefits)

Structural heart disease refers to problems with the heart’s physical components—most often the valves (aortic, mitral, tricuspid, pulmonic), but also the septum (the wall between heart chambers) and other internal structures. These conditions can reduce forward blood flow, cause backward leakage, raise pressure in the lungs, trigger symptoms like shortness of breath or fatigue, and increase strain on the heart over time.

A Structural Heart Program exists to address common gaps in care that can occur when complex heart conditions are evaluated in a fragmented way. The main purposes include:

Accurate diagnosis and severity grading. Valve narrowing (stenosis) and valve leakage (regurgitation) are not “one-size-fits-all.” Programs emphasize consistent imaging and interpretation to define how severe a problem is and whether it explains a patient’s symptoms.
Risk stratification for procedures. Many structural interventions are considered in people with multiple medical conditions. Programs aim to clarify procedural risk using imaging, functional assessment, and multidisciplinary review.
Matching the right therapy to the right anatomy. Some patients are best treated with medication and monitoring, some with catheter-based procedures, and others with surgery. A program helps align treatment options with valve anatomy, heart function, and overall health.
Access to specialized procedures and teams. Structural interventions often require a “heart team” model—interventional cardiology, cardiac surgery, imaging experts, anesthesia, nursing, and rehabilitation working together.
Symptom evaluation and care coordination. Symptoms such as breathlessness can come from valve disease, coronary disease, lung disease, anemia, deconditioning, or a combination. Programs commonly coordinate testing to identify the main drivers.
Longitudinal follow-up. Valve and device conditions can change over time. Programs often set structured follow-up plans for imaging, medication reconciliation, and functional recovery.

Overall, the benefit is not a single test or procedure—it is a system of care designed to evaluate structural problems precisely, select appropriate interventions when needed, and coordinate follow-up across specialties.

Clinical context (When cardiologists or cardiovascular clinicians use it)

Clinicians commonly involve a Structural Heart Program in scenarios such as:

A new or worsening heart murmur with suspected aortic stenosis or mitral regurgitation
Heart failure symptoms where valve disease may be contributing (especially with reduced or preserved ejection fraction)
Consideration of transcatheter aortic valve replacement (TAVR) for severe aortic stenosis
Consideration of transcatheter edge-to-edge repair (TEER) for mitral or tricuspid regurgitation (procedure availability varies by center)
Work-up of paravalvular leak (leak around a prior surgical or transcatheter valve), when suspected by imaging or symptoms
Evaluation for left atrial appendage occlusion in selected patients with atrial fibrillation when long-term anticoagulation is challenging (candidacy varies by clinician and case)
Assessment of atrial septal defect (ASD) or patent foramen ovale (PFO) for possible closure in selected situations (indications vary by clinician and case)
Complex imaging questions, such as discordant echocardiogram findings or unclear valve severity
Planning for intervention in people with multiple comorbidities who may benefit from a multidisciplinary review

Contraindications / when it’s NOT ideal

A Structural Heart Program is a care model rather than a single therapy, so “contraindications” typically relate to specific interventions (for example, valve replacement, valve repair, or device closure). Situations where a program-driven structural procedure may not be suitable include:

Symptoms not primarily caused by structural disease. If shortness of breath is mainly due to lung disease, anemia, or deconditioning, a structural procedure may not address the main problem.
Valve or device anatomy that is unsuitable for a specific catheter-based approach. Some valve shapes, calcification patterns, annulus sizes, or access vessel sizes may not accommodate certain devices or techniques. Suitability varies by material and manufacturer.
Active infection. Ongoing bloodstream infection or infective endocarditis generally makes elective valve/device procedures inappropriate until infection is treated and reassessed.
Uncontrolled bleeding risk or inability to take necessary antithrombotic therapy. Many procedures require short-term antiplatelet and/or anticoagulant therapy; appropriateness varies by clinician and case.
Severe frailty or advanced multisystem illness where the expected improvement in symptoms or quality of life is uncertain. Decisions often require individualized discussion and shared decision-making.
Unstable clinical status requiring urgent stabilization (for example, shock or severe respiratory failure). In these settings, teams may prioritize stabilization and targeted diagnostics before considering structural intervention.
Preferable alternative approach. Some patients are better served by surgical valve repair/replacement, medical therapy, palliative-focused care, or watchful monitoring depending on goals, anatomy, and overall risk.

How it works (Mechanism / physiology)

A Structural Heart Program does not have a single physiologic “mechanism” like a medication does. Instead, it applies a structured approach to identify structural problems and restore more normal cardiac physiology when intervention is appropriate.

Key physiologic principles commonly addressed include:

Forward flow across valves. In stenosis (narrowing), the heart must generate higher pressures to push blood forward. This can lead to thickening of the heart muscle (hypertrophy), reduced exercise capacity, and eventually heart failure symptoms.
Prevention of backward leak. In regurgitation (leakage), blood flows in the wrong direction, increasing volume load on the heart chambers. Over time this can enlarge chambers and worsen function.
Pressure and volume relationships. Valve disease affects pressures in the left atrium, pulmonary veins, lungs, and right heart. This helps explain symptoms like breathlessness and swelling.
Interaction with heart rhythm and the conduction system. Some interventions (especially near the aortic valve) can affect the heart’s electrical pathways and may increase the need for pacing in some cases. The likelihood varies by clinician, case, and device type.
Thromboembolism risk in atrial fibrillation. For left atrial appendage occlusion, the physiologic goal is to reduce clot formation in a specific atrial structure that can contribute to stroke risk in atrial fibrillation.

Relevant anatomy commonly evaluated includes:

Valves: aortic, mitral, tricuspid, pulmonic
Chambers: left ventricle, left atrium, right ventricle, right atrium
Septum: interatrial septum (between atria), interventricular septum (between ventricles)
Great vessels and access routes: femoral arteries/veins, aorta, vena cava
Left atrial appendage (a small pouch connected to the left atrium)

Time course and interpretation:

Diagnostic findings (imaging and hemodynamics) guide whether intervention is needed now, later, or not at all.
After an intervention, physiologic improvement can be immediate (improved valve opening/closure) while symptom improvement may take weeks to months and depends on other conditions, baseline heart function, and rehabilitation.
Some structural conditions are progressive, so reassessment over time is common even when initial management is monitoring.

Structural Heart Program Procedure overview (How it’s applied)

Because a Structural Heart Program is not one procedure, the “application” is best understood as a standardized pathway from evaluation through follow-up. Many centers use a heart-team process.

A typical workflow may include:

Evaluation / exam – Symptom history (shortness of breath, chest discomfort, fainting, fatigue, swelling) – Physical exam and review of murmurs, heart failure signs, and rhythm issues – Review of prior cardiac history (valves, stents, bypass surgery, arrhythmias)
Diagnostic testing – Echocardiography (ultrasound of the heart), often transthoracic and sometimes transesophageal depending on the question – CT imaging for anatomy and procedural planning in selected cases (for example, valve sizing and vascular access) – Cardiac catheterization or coronary assessment when indicated (varies by clinician and case) – Functional assessment (walk testing or similar) and lab evaluation as appropriate
Preparation / planning – Heart-team review with interventional cardiology, cardiac surgery, cardiac imaging, anesthesia, and nursing – Shared decision-making discussions about goals of care, expected benefits, and tradeoffs – Planning for access route (commonly through leg vessels for many catheter-based procedures) when relevant
Intervention / procedure (when appropriate) – Catheter-based therapy (for example, transcatheter valve replacement/repair or device closure) or surgery – Anesthesia plan and intraprocedural imaging guidance as needed (practice varies by center)
Immediate checks – Post-procedure imaging to confirm device position and function when relevant – Monitoring for rhythm changes, bleeding, kidney function changes, and access-site complications – Medication reconciliation (for example, antiplatelet/anticoagulant strategy varies by clinician and case)
Follow-up – Clinic visits and repeat echocardiography on a program-defined schedule – Assessment of symptoms, exercise tolerance, and heart failure status – Coordination with cardiac rehabilitation or supervised exercise programs when appropriate and available

Types / variations

Structural care can differ significantly by condition and by what a center offers. Common Structural Heart Program tracks include:

Aortic valve disease
Evaluation for aortic stenosis and aortic regurgitation
Options may include surgical aortic valve replacement or transcatheter approaches (such as TAVR), depending on candidacy
Mitral valve disease
Degenerative (primary) mitral regurgitation vs functional (secondary) mitral regurgitation related to cardiomyopathy
Options can include surgical repair/replacement or catheter-based repair in selected patients (availability and candidacy vary)
Tricuspid valve disease
Often functional regurgitation related to right heart enlargement or pulmonary hypertension
Some centers offer emerging catheter-based approaches; eligibility and evidence base vary by clinician and case
Pulmonic valve disease
More commonly discussed in congenital heart disease settings and post-surgical patients
Septal and shunt conditions
ASD closure, selected PFO closure evaluations, and other structural communications when appropriate
Left atrial appendage occlusion
Considered in selected atrial fibrillation patients where stroke prevention strategies require individualized planning
Paravalvular leak and valve-in-valve pathways
Evaluation of leaks around prior valves or degeneration of prior surgical bioprosthetic valves
Options may include catheter-based closure or valve-in-valve strategies depending on anatomy and device compatibility (varies by material and manufacturer)

Programs also vary by approach and setting:

Diagnostic-focused vs interventional-focused programs (some centers evaluate and refer out for procedures)
Catheter-based vs surgical emphasis (often both, integrated by a heart team)
Imaging intensity (some programs have dedicated structural imaging specialists and advanced CT/echo protocols)
Hybrid operating room capability (combined surgical and catheter-based environment), depending on facility resources

Pros and cons

Pros:

Multidisciplinary evaluation that integrates cardiology, cardiac surgery, imaging, and anesthesia
More consistent grading of valve disease severity using standardized imaging pathways
Ability to compare catheter-based and surgical options within one coordinated team
Streamlined procedural planning (imaging, access assessment, device sizing when relevant)
Structured follow-up that can detect progression of disease or device/valve issues early
Improved coordination for complex patients with multiple conditions (heart failure, kidney disease, lung disease)

Cons:

Availability varies by region; some patients may need referral or travel
Not every patient is a candidate for catheter-based structural interventions
Work-ups can involve multiple visits and tests, which may feel time-intensive
Procedures can still carry meaningful risks (bleeding, stroke, rhythm issues, vascular complications), varying by clinician and case
Insurance coverage and prior authorization processes can be complex and vary by plan and location
Some technologies are evolving; the most appropriate approach may be uncertain in borderline cases

Aftercare & longevity

Aftercare depends on the specific condition and whether the pathway involved monitoring, a catheter-based intervention, or surgery. In general, outcomes and “longevity” of results are influenced by:

Underlying disease severity and heart function at the time of evaluation (earlier vs later stages can differ in recovery potential)
Comorbidities such as chronic kidney disease, diabetes, lung disease, anemia, frailty, and vascular disease
Heart rhythm status, especially atrial fibrillation, which can affect symptoms and anticoagulation decisions
Valve or device factors, including type of valve (mechanical vs bioprosthetic in surgical contexts), device design, and procedural fit; durability varies by material and manufacturer
Follow-up consistency, including repeat echocardiograms and clinic assessments to identify recurrence of leakage, valve gradients, or other changes
Medication management (for example, antiplatelet or anticoagulation plans when relevant), which varies by clinician and case
Functional recovery, including physical conditioning and symptom-guided activity progression; some patients benefit from structured cardiac rehabilitation when offered

It is common for programs to schedule periodic imaging even when a patient feels well, because some structural changes develop gradually and may be detected before symptoms become obvious.

Alternatives / comparisons

A Structural Heart Program often helps patients and clinicians compare multiple management pathways. Common alternatives and comparisons include:

Observation/monitoring vs intervention
Mild or moderate valve disease may be followed with periodic imaging and symptom checks.
Severe disease or symptom-linked disease is more likely to prompt discussion of procedural options, but timing varies by clinician and case.
Medication management vs structural repair
Medications can reduce congestion, control blood pressure, and support heart failure management, but they typically do not “open” a severely narrowed valve.
For certain regurgitant lesions, optimizing heart failure therapy can reduce functional leakage, while primary (degenerative) valve problems may require repair/replacement for definitive correction.
Noninvasive testing vs invasive testing
Echocardiography and CT are noninvasive tools that answer many structural questions.
Cardiac catheterization or transesophageal echocardiography may be used when clarification is needed or when procedural planning requires additional detail.
Catheter-based vs surgical approaches
Catheter-based therapies are less invasive and may shorten recovery time for some patients, but not every anatomy is suitable.
Surgery can address a wider range of anatomies and may be preferred in certain valve diseases, combined conditions, or in patients already needing another cardiac surgery. The choice depends on risk, anatomy, and goals, and varies by clinician and case.
Center expertise and program scope
Some centers offer a broad device portfolio and advanced imaging support, while others focus on evaluation and referral.
When comparing options, clinicians often consider local experience, procedural volume, and the ability to manage complications—factors that can differ across institutions.

Structural Heart Program Common questions (FAQ)

Q: Is a Structural Heart Program the same as a cardiology clinic?
A Structural Heart Program is usually a specialized part of cardiology focused on heart valves and related structures. It often uses a heart-team model that includes interventional cardiologists, cardiac surgeons, and specialized imaging clinicians. A general cardiology clinic may refer to the program when valve or structural problems become more complex.

Q: What conditions are most commonly evaluated in a Structural Heart Program?
Valve diseases—especially aortic stenosis and mitral regurgitation—are common reasons for referral. Programs may also evaluate tricuspid disease, paravalvular leak, septal defects, and left atrial appendage occlusion candidacy. The exact scope varies by center.

Q: What tests might be done during the evaluation?
Echocardiography is central because it measures valve function and heart chamber size and pumping strength. Many programs also use CT imaging for anatomy and procedural planning in selected cases. Additional testing may include stress/functional assessment or catheter-based evaluation depending on the clinical question.

Q: Are Structural Heart Program procedures painful?
Many catheter-based procedures are done with sedation or anesthesia, so discomfort during the procedure is often limited. Afterward, patients may notice soreness or bruising at an access site (often in the groin) or general fatigue. Experiences vary by clinician, case, and procedure type.

Q: How long do results last after a structural heart intervention?
It depends on the condition treated and the device or valve type used. Some repairs provide durable improvement, while others may gradually change over time and require monitoring. Durability varies by material and manufacturer, as well as by individual anatomy and comorbidities.

Q: How safe are these evaluations and procedures?
Diagnostic testing like echocardiography is generally low risk. Invasive procedures carry risks such as bleeding, vascular complications, stroke, kidney injury, infection, and rhythm problems, with likelihood influenced by patient factors and procedural complexity. A Structural Heart Program typically reviews these risks in a structured, case-specific way.

Q: Will I need to stay in the hospital?
Some evaluations are outpatient, while many interventions involve at least short hospital observation. The length of stay depends on the procedure, overall health, and whether monitoring is needed for rhythm or access-site issues. Hospitalization needs vary by clinician and case.

Q: Are there activity restrictions after a procedure?
Short-term limitations often relate to allowing an access site to heal and monitoring symptoms as conditioning returns. The type and duration of restrictions depend on the intervention and individual recovery factors. Programs commonly provide personalized instructions, which vary by clinician and case.

Q: What does a “heart team” mean, and why does it matter?
A heart team is a group of specialists who jointly review imaging, anatomy, symptoms, and procedural options. This approach helps compare catheter-based and surgical strategies and can improve care coordination for complex decisions. Team composition and workflow vary by institution.

Q: What does a Structural Heart Program cost?
Costs depend on the tests performed, whether a procedure is done, length of hospital stay, insurance coverage, and regional pricing. Different devices and approaches can have different cost profiles, and coverage rules vary by plan. Many centers have financial counseling teams to help explain expected billing categories without guaranteeing totals.